CPHI vs JLL · rev $4.1M vs P/E 23, rev $23.43B
China Pharma Holdings Inc (CPHI) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
CPHI currently screens at market cap $29.0M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the CPHI and JLL stock pages for the full models.
Not investment advice.